>
Floating Energy Assets Explained
What if Iran's next move against Washington is not a missile launch, but a convoy of oil tankers
Artificial Intelligence Could Transform Bank Runs From Hours-Long Crises...
Dubai Just Finished the World's First Permanent Air Taxi Route: Airport to the Marina in Under 1
Doroni Aerospace Raises More than $60m for H1?X Development
After 13 Years Battling Cancer, a 61-Year-Old Brazilian Man Achieved Complete Remission...
Extraterrestrial habitats may rise via Legos of laser-fused moon dust
Battery-only 19-seater puts China in the electric airliner race
Dream Chaser space plane gets landing approval for debut mission in 2027
SpaceX Just Caught Starship on Its FIRST Attempt!
Solid-State Cells Can Make The U.S. Competitive In Batteries Again: CEO
Jetson ONE personal eVTOL pod is about to go full sky patrol
America's INSANE BREAKTHROUGH Could Replace Septic Tanks Forever

The Oxford-AstraZeneca coronavirus vaccine will be withdrawn worldwide just months after the firm admitted that the jab causes a rare but dangerous side effect, however, AstraZeneca insists that the decision to pull the vaccine was purely made for commercial reasons.
AstraZeneca pulled its "marketing authorisation" for its COVID-19 vaccine, known commercially as Vaxzevria, in the European Union on Tuesday and plans to do so in the UK and other countries where it was deployed in the coming months. The decision will not impact the United States, where the jab never received approval to go to market.
The pharmaceutical giant insisted that the decision was made for commercial considerations, saying that the vaccine is no longer being manufactured and that more recent vaccines have been developed to confront novel variants of the Chinese virus.